Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRG | P48443 | 1/20 | 0.32 |
| ▸ | MAT2A | P31153 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | IDH1 | O75874 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20155940 | 0.94 | RXRA (0.34) | RXRARXRGMAT2AKIF11IDH1 | |
| SCHEMBL20150356 | 0.92 | SYK (0.33) | SYKRXRARXRGMAT2AKIF11 | |
| SCHEMBL20150358 | 0.91 | HCRTR1 (0.30) | HCRTR1HCRTR2 | |
| SCHEMBL20155938 | 0.90 | — | — | |
| SCHEMBL20150357 | 0.89 | PTGER4 (0.33) | SYKRXRARXRGMAT2AKIF11 | |
| SCHEMBL20849082 | 0.89 | RXRA (0.33) | RXRARXRGMAT2AKIF11PTGER4 | |
| SCHEMBL20849118 | 0.87 | RXRA (0.35) | SYKRXRARXRGKIF11 | |
| SCHEMBL20848961 | 0.87 | CTSS (0.32) | RXRARXRGMAT2AKIF11PTGER4 | |
| SCHEMBL20150364 | 0.87 | PTGER4 (0.35) | SYKRXRARXRGMAT2APTGER4 | |
| SCHEMBL20156274 | 0.87 | RXRA (0.34) | RXRARXRGKIF11GRM5HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | SYK 338/4885RXRA 2913/4885RXRG 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.